nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemifloxacin—Sparfloxacin—ABCB1—colon cancer	0.00367	0.419	CrCbGaD
Gemifloxacin—Hyponatraemia—Capecitabine—colon cancer	0.00303	0.00305	CcSEcCtD
Gemifloxacin—Visual impairment—Irinotecan—colon cancer	0.003	0.00303	CcSEcCtD
Gemifloxacin—Haemoglobin—Fluorouracil—colon cancer	0.003	0.00303	CcSEcCtD
Gemifloxacin—Haemorrhage—Fluorouracil—colon cancer	0.00298	0.00301	CcSEcCtD
Gemifloxacin—Cardiac disorder—Vincristine—colon cancer	0.00297	0.003	CcSEcCtD
Gemifloxacin—Pharyngitis—Fluorouracil—colon cancer	0.00296	0.00299	CcSEcCtD
Gemifloxacin—Skin exfoliation—Methotrexate—colon cancer	0.00295	0.00298	CcSEcCtD
Gemifloxacin—Vaginal infection—Methotrexate—colon cancer	0.00292	0.00294	CcSEcCtD
Gemifloxacin—Face oedema—Capecitabine—colon cancer	0.00291	0.00294	CcSEcCtD
Gemifloxacin—Angiopathy—Vincristine—colon cancer	0.0029	0.00293	CcSEcCtD
Gemifloxacin—Cardiac disorder—Irinotecan—colon cancer	0.00289	0.00292	CcSEcCtD
Gemifloxacin—Flushing—Irinotecan—colon cancer	0.00289	0.00292	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Vincristine—colon cancer	0.00288	0.00291	CcSEcCtD
Gemifloxacin—Angiopathy—Irinotecan—colon cancer	0.00283	0.00285	CcSEcCtD
Gemifloxacin—Blood creatinine increased—Capecitabine—colon cancer	0.00282	0.00285	CcSEcCtD
Gemifloxacin—Immune system disorder—Irinotecan—colon cancer	0.00281	0.00284	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Irinotecan—colon cancer	0.00281	0.00283	CcSEcCtD
Gemifloxacin—Mental disorder—Vincristine—colon cancer	0.0028	0.00283	CcSEcCtD
Gemifloxacin—Mouth ulceration—Methotrexate—colon cancer	0.00279	0.00282	CcSEcCtD
Gemifloxacin—Breast disorder—Capecitabine—colon cancer	0.00272	0.00275	CcSEcCtD
Gemifloxacin—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.00271	0.00274	CcSEcCtD
Gemifloxacin—Back pain—Vincristine—colon cancer	0.00269	0.00272	CcSEcCtD
Gemifloxacin—Flatulence—Irinotecan—colon cancer	0.00267	0.0027	CcSEcCtD
Gemifloxacin—Gastritis—Capecitabine—colon cancer	0.00267	0.00269	CcSEcCtD
Gemifloxacin—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00266	0.00268	CcSEcCtD
Gemifloxacin—Back pain—Irinotecan—colon cancer	0.00262	0.00265	CcSEcCtD
Gemifloxacin—Muscle spasms—Irinotecan—colon cancer	0.00261	0.00263	CcSEcCtD
Gemifloxacin—Dysphagia—Capecitabine—colon cancer	0.00261	0.00263	CcSEcCtD
Gemifloxacin—Levofloxacin—ABCB1—colon cancer	0.00258	0.295	CrCbGaD
Gemifloxacin—Anaemia—Vincristine—colon cancer	0.00257	0.0026	CcSEcCtD
Gemifloxacin—Photosensitivity—Methotrexate—colon cancer	0.00256	0.00258	CcSEcCtD
Gemifloxacin—Anaemia—Irinotecan—colon cancer	0.00251	0.00253	CcSEcCtD
Gemifloxacin—Vertigo—Vincristine—colon cancer	0.0025	0.00252	CcSEcCtD
Gemifloxacin—Ciprofloxacin—ABCB1—colon cancer	0.00249	0.285	CrCbGaD
Gemifloxacin—Leukopenia—Vincristine—colon cancer	0.00249	0.00252	CcSEcCtD
Gemifloxacin—Vertigo—Irinotecan—colon cancer	0.00244	0.00246	CcSEcCtD
Gemifloxacin—Syncope—Irinotecan—colon cancer	0.00243	0.00245	CcSEcCtD
Gemifloxacin—Renal failure acute—Methotrexate—colon cancer	0.00243	0.00245	CcSEcCtD
Gemifloxacin—Leukopenia—Irinotecan—colon cancer	0.00243	0.00245	CcSEcCtD
Gemifloxacin—Anaemia—Fluorouracil—colon cancer	0.0024	0.00242	CcSEcCtD
Gemifloxacin—Loss of consciousness—Irinotecan—colon cancer	0.00238	0.0024	CcSEcCtD
Gemifloxacin—Photosensitivity reaction—Capecitabine—colon cancer	0.00238	0.0024	CcSEcCtD
Gemifloxacin—Myalgia—Vincristine—colon cancer	0.00237	0.00239	CcSEcCtD
Gemifloxacin—Hyperglycaemia—Capecitabine—colon cancer	0.00235	0.00237	CcSEcCtD
Gemifloxacin—Pneumonia—Capecitabine—colon cancer	0.00234	0.00236	CcSEcCtD
Gemifloxacin—Leukopenia—Fluorouracil—colon cancer	0.00233	0.00235	CcSEcCtD
Gemifloxacin—Infestation NOS—Capecitabine—colon cancer	0.00232	0.00234	CcSEcCtD
Gemifloxacin—Infestation—Capecitabine—colon cancer	0.00232	0.00234	CcSEcCtD
Gemifloxacin—Renal failure—Capecitabine—colon cancer	0.00228	0.0023	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Capecitabine—colon cancer	0.00228	0.0023	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Vincristine—colon cancer	0.00227	0.00229	CcSEcCtD
Gemifloxacin—Oedema—Vincristine—colon cancer	0.00227	0.00229	CcSEcCtD
Gemifloxacin—Stomatitis—Capecitabine—colon cancer	0.00226	0.00228	CcSEcCtD
Gemifloxacin—Nervous system disorder—Vincristine—colon cancer	0.00223	0.00225	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Vincristine—colon cancer	0.00223	0.00225	CcSEcCtD
Gemifloxacin—Haematuria—Capecitabine—colon cancer	0.00221	0.00223	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Irinotecan—colon cancer	0.00221	0.00223	CcSEcCtD
Gemifloxacin—Oedema—Irinotecan—colon cancer	0.00221	0.00223	CcSEcCtD
Gemifloxacin—Myalgia—Fluorouracil—colon cancer	0.00221	0.00223	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Vincristine—colon cancer	0.0022	0.00222	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Capecitabine—colon cancer	0.0022	0.00222	CcSEcCtD
Gemifloxacin—Shock—Irinotecan—colon cancer	0.00218	0.0022	CcSEcCtD
Gemifloxacin—Nervous system disorder—Irinotecan—colon cancer	0.00217	0.00219	CcSEcCtD
Gemifloxacin—Agranulocytosis—Capecitabine—colon cancer	0.00217	0.00219	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Irinotecan—colon cancer	0.00217	0.00219	CcSEcCtD
Gemifloxacin—Anorexia—Vincristine—colon cancer	0.00217	0.00219	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Irinotecan—colon cancer	0.00214	0.00216	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Fluorouracil—colon cancer	0.00212	0.00214	CcSEcCtD
Gemifloxacin—Oedema—Fluorouracil—colon cancer	0.00212	0.00214	CcSEcCtD
Gemifloxacin—Anorexia—Irinotecan—colon cancer	0.00211	0.00213	CcSEcCtD
Gemifloxacin—Haemoglobin—Capecitabine—colon cancer	0.0021	0.00211	CcSEcCtD
Gemifloxacin—Haemorrhage—Capecitabine—colon cancer	0.00209	0.0021	CcSEcCtD
Gemifloxacin—Nervous system disorder—Fluorouracil—colon cancer	0.00208	0.0021	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Fluorouracil—colon cancer	0.00208	0.00209	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Vincristine—colon cancer	0.00207	0.00209	CcSEcCtD
Gemifloxacin—Pharyngitis—Capecitabine—colon cancer	0.00207	0.00209	CcSEcCtD
Gemifloxacin—Tachycardia—Fluorouracil—colon cancer	0.00207	0.00209	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Capecitabine—colon cancer	0.00206	0.00208	CcSEcCtD
Gemifloxacin—Insomnia—Vincristine—colon cancer	0.00206	0.00207	CcSEcCtD
Gemifloxacin—Oedema peripheral—Capecitabine—colon cancer	0.00205	0.00207	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Capecitabine—colon cancer	0.00205	0.00207	CcSEcCtD
Gemifloxacin—Urethral disorder—Capecitabine—colon cancer	0.00204	0.00206	CcSEcCtD
Gemifloxacin—Breast disorder—Methotrexate—colon cancer	0.00203	0.00205	CcSEcCtD
Gemifloxacin—Anorexia—Fluorouracil—colon cancer	0.00202	0.00204	CcSEcCtD
Gemifloxacin—Visual impairment—Capecitabine—colon cancer	0.00201	0.00203	CcSEcCtD
Gemifloxacin—Insomnia—Irinotecan—colon cancer	0.002	0.00202	CcSEcCtD
Gemifloxacin—Decreased appetite—Vincristine—colon cancer	0.00198	0.00199	CcSEcCtD
Gemifloxacin—Dyspnoea—Irinotecan—colon cancer	0.00197	0.00199	CcSEcCtD
Gemifloxacin—Erythema multiforme—Capecitabine—colon cancer	0.00197	0.00199	CcSEcCtD
Gemifloxacin—Somnolence—Irinotecan—colon cancer	0.00197	0.00199	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Vincristine—colon cancer	0.00196	0.00198	CcSEcCtD
Gemifloxacin—Fatigue—Vincristine—colon cancer	0.00196	0.00198	CcSEcCtD
Gemifloxacin—Eye disorder—Capecitabine—colon cancer	0.00195	0.00197	CcSEcCtD
Gemifloxacin—Dyspepsia—Irinotecan—colon cancer	0.00195	0.00197	CcSEcCtD
Gemifloxacin—Pain—Vincristine—colon cancer	0.00194	0.00196	CcSEcCtD
Gemifloxacin—Constipation—Vincristine—colon cancer	0.00194	0.00196	CcSEcCtD
Gemifloxacin—Cardiac disorder—Capecitabine—colon cancer	0.00194	0.00195	CcSEcCtD
Gemifloxacin—Flushing—Capecitabine—colon cancer	0.00194	0.00195	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00193	0.00195	CcSEcCtD
Gemifloxacin—Decreased appetite—Irinotecan—colon cancer	0.00192	0.00194	CcSEcCtD
Gemifloxacin—Eosinophilia—Methotrexate—colon cancer	0.00192	0.00194	CcSEcCtD
Gemifloxacin—Insomnia—Fluorouracil—colon cancer	0.00192	0.00193	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Irinotecan—colon cancer	0.00191	0.00193	CcSEcCtD
Gemifloxacin—Fatigue—Irinotecan—colon cancer	0.00191	0.00193	CcSEcCtD
Gemifloxacin—Pancreatitis—Methotrexate—colon cancer	0.0019	0.00192	CcSEcCtD
Gemifloxacin—Pain—Irinotecan—colon cancer	0.00189	0.00191	CcSEcCtD
Gemifloxacin—Constipation—Irinotecan—colon cancer	0.00189	0.00191	CcSEcCtD
Gemifloxacin—Angiopathy—Capecitabine—colon cancer	0.00189	0.00191	CcSEcCtD
Gemifloxacin—Dyspnoea—Fluorouracil—colon cancer	0.00189	0.00191	CcSEcCtD
Gemifloxacin—Somnolence—Fluorouracil—colon cancer	0.00188	0.0019	CcSEcCtD
Gemifloxacin—Immune system disorder—Capecitabine—colon cancer	0.00188	0.0019	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Capecitabine—colon cancer	0.00188	0.0019	CcSEcCtD
Gemifloxacin—Dyspepsia—Fluorouracil—colon cancer	0.00187	0.00188	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Vincristine—colon cancer	0.00186	0.00188	CcSEcCtD
Gemifloxacin—Decreased appetite—Fluorouracil—colon cancer	0.00184	0.00186	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00183	0.00185	CcSEcCtD
Gemifloxacin—Mental disorder—Capecitabine—colon cancer	0.00183	0.00184	CcSEcCtD
Gemifloxacin—Pain—Fluorouracil—colon cancer	0.00181	0.00183	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Irinotecan—colon cancer	0.00181	0.00183	CcSEcCtD
Gemifloxacin—Abdominal pain—Vincristine—colon cancer	0.0018	0.00181	CcSEcCtD
Gemifloxacin—Body temperature increased—Vincristine—colon cancer	0.0018	0.00181	CcSEcCtD
Gemifloxacin—Flatulence—Capecitabine—colon cancer	0.00179	0.0018	CcSEcCtD
Gemifloxacin—Dysgeusia—Capecitabine—colon cancer	0.00178	0.00179	CcSEcCtD
Gemifloxacin—Photosensitivity reaction—Methotrexate—colon cancer	0.00177	0.00179	CcSEcCtD
Gemifloxacin—Back pain—Capecitabine—colon cancer	0.00176	0.00177	CcSEcCtD
Gemifloxacin—Abdominal pain—Irinotecan—colon cancer	0.00175	0.00177	CcSEcCtD
Gemifloxacin—Body temperature increased—Irinotecan—colon cancer	0.00175	0.00177	CcSEcCtD
Gemifloxacin—Muscle spasms—Capecitabine—colon cancer	0.00175	0.00176	CcSEcCtD
Gemifloxacin—Pneumonia—Methotrexate—colon cancer	0.00174	0.00175	CcSEcCtD
Gemifloxacin—Infestation—Methotrexate—colon cancer	0.00173	0.00174	CcSEcCtD
Gemifloxacin—Infestation NOS—Methotrexate—colon cancer	0.00173	0.00174	CcSEcCtD
Gemifloxacin—Tremor—Capecitabine—colon cancer	0.0017	0.00172	CcSEcCtD
Gemifloxacin—Renal failure—Methotrexate—colon cancer	0.0017	0.00171	CcSEcCtD
Gemifloxacin—Stomatitis—Methotrexate—colon cancer	0.00169	0.0017	CcSEcCtD
Gemifloxacin—Urticaria—Fluorouracil—colon cancer	0.00168	0.0017	CcSEcCtD
Gemifloxacin—Anaemia—Capecitabine—colon cancer	0.00168	0.00169	CcSEcCtD
Gemifloxacin—Body temperature increased—Fluorouracil—colon cancer	0.00168	0.00169	CcSEcCtD
Gemifloxacin—Haematuria—Methotrexate—colon cancer	0.00165	0.00166	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Methotrexate—colon cancer	0.00164	0.00165	CcSEcCtD
Gemifloxacin—Vertigo—Capecitabine—colon cancer	0.00163	0.00165	CcSEcCtD
Gemifloxacin—Asthenia—Vincristine—colon cancer	0.00163	0.00165	CcSEcCtD
Gemifloxacin—Syncope—Capecitabine—colon cancer	0.00163	0.00164	CcSEcCtD
Gemifloxacin—Leukopenia—Capecitabine—colon cancer	0.00162	0.00164	CcSEcCtD
Gemifloxacin—Agranulocytosis—Methotrexate—colon cancer	0.00161	0.00163	CcSEcCtD
Gemifloxacin—Palpitations—Capecitabine—colon cancer	0.0016	0.00162	CcSEcCtD
Gemifloxacin—Loss of consciousness—Capecitabine—colon cancer	0.0016	0.00161	CcSEcCtD
Gemifloxacin—Asthenia—Irinotecan—colon cancer	0.00159	0.0016	CcSEcCtD
Gemifloxacin—Haemoglobin—Methotrexate—colon cancer	0.00156	0.00157	CcSEcCtD
Gemifloxacin—Diarrhoea—Vincristine—colon cancer	0.00156	0.00157	CcSEcCtD
Gemifloxacin—Haemorrhage—Methotrexate—colon cancer	0.00155	0.00157	CcSEcCtD
Gemifloxacin—Myalgia—Capecitabine—colon cancer	0.00155	0.00156	CcSEcCtD
Gemifloxacin—Arthralgia—Capecitabine—colon cancer	0.00155	0.00156	CcSEcCtD
Gemifloxacin—Pharyngitis—Methotrexate—colon cancer	0.00154	0.00155	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00153	0.00155	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Methotrexate—colon cancer	0.00153	0.00155	CcSEcCtD
Gemifloxacin—Urethral disorder—Methotrexate—colon cancer	0.00152	0.00154	CcSEcCtD
Gemifloxacin—Diarrhoea—Irinotecan—colon cancer	0.00151	0.00153	CcSEcCtD
Gemifloxacin—Dry mouth—Capecitabine—colon cancer	0.00151	0.00152	CcSEcCtD
Gemifloxacin—Dizziness—Vincristine—colon cancer	0.0015	0.00152	CcSEcCtD
Gemifloxacin—Pruritus—Fluorouracil—colon cancer	0.0015	0.00151	CcSEcCtD
Gemifloxacin—Visual impairment—Methotrexate—colon cancer	0.0015	0.00151	CcSEcCtD
Gemifloxacin—Oedema—Capecitabine—colon cancer	0.00148	0.00149	CcSEcCtD
Gemifloxacin—Erythema multiforme—Methotrexate—colon cancer	0.00147	0.00148	CcSEcCtD
Gemifloxacin—Dizziness—Irinotecan—colon cancer	0.00146	0.00148	CcSEcCtD
Gemifloxacin—Shock—Capecitabine—colon cancer	0.00146	0.00147	CcSEcCtD
Gemifloxacin—Nervous system disorder—Capecitabine—colon cancer	0.00145	0.00147	CcSEcCtD
Gemifloxacin—Eye disorder—Methotrexate—colon cancer	0.00145	0.00146	CcSEcCtD
Gemifloxacin—Diarrhoea—Fluorouracil—colon cancer	0.00145	0.00146	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Capecitabine—colon cancer	0.00145	0.00146	CcSEcCtD
Gemifloxacin—Tachycardia—Capecitabine—colon cancer	0.00145	0.00146	CcSEcCtD
Gemifloxacin—Vomiting—Vincristine—colon cancer	0.00145	0.00146	CcSEcCtD
Gemifloxacin—Cardiac disorder—Methotrexate—colon cancer	0.00144	0.00145	CcSEcCtD
Gemifloxacin—Skin disorder—Capecitabine—colon cancer	0.00144	0.00145	CcSEcCtD
Gemifloxacin—Rash—Vincristine—colon cancer	0.00143	0.00145	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Capecitabine—colon cancer	0.00143	0.00144	CcSEcCtD
Gemifloxacin—Dermatitis—Vincristine—colon cancer	0.00143	0.00144	CcSEcCtD
Gemifloxacin—Headache—Vincristine—colon cancer	0.00142	0.00144	CcSEcCtD
Gemifloxacin—Anorexia—Capecitabine—colon cancer	0.00141	0.00142	CcSEcCtD
Gemifloxacin—Angiopathy—Methotrexate—colon cancer	0.00141	0.00142	CcSEcCtD
Gemifloxacin—Vomiting—Irinotecan—colon cancer	0.00141	0.00142	CcSEcCtD
Gemifloxacin—Immune system disorder—Methotrexate—colon cancer	0.0014	0.00141	CcSEcCtD
Gemifloxacin—Dizziness—Fluorouracil—colon cancer	0.0014	0.00141	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Methotrexate—colon cancer	0.0014	0.00141	CcSEcCtD
Gemifloxacin—Rash—Irinotecan—colon cancer	0.0014	0.00141	CcSEcCtD
Gemifloxacin—Dermatitis—Irinotecan—colon cancer	0.00139	0.00141	CcSEcCtD
Gemifloxacin—Headache—Irinotecan—colon cancer	0.00139	0.0014	CcSEcCtD
Gemifloxacin—Mental disorder—Methotrexate—colon cancer	0.00136	0.00137	CcSEcCtD
Gemifloxacin—Nausea—Vincristine—colon cancer	0.00135	0.00136	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00135	0.00136	CcSEcCtD
Gemifloxacin—Vomiting—Fluorouracil—colon cancer	0.00135	0.00136	CcSEcCtD
Gemifloxacin—Insomnia—Capecitabine—colon cancer	0.00134	0.00135	CcSEcCtD
Gemifloxacin—Rash—Fluorouracil—colon cancer	0.00134	0.00135	CcSEcCtD
Gemifloxacin—Dermatitis—Fluorouracil—colon cancer	0.00134	0.00135	CcSEcCtD
Gemifloxacin—Headache—Fluorouracil—colon cancer	0.00133	0.00134	CcSEcCtD
Gemifloxacin—Dysgeusia—Methotrexate—colon cancer	0.00132	0.00134	CcSEcCtD
Gemifloxacin—Dyspnoea—Capecitabine—colon cancer	0.00132	0.00133	CcSEcCtD
Gemifloxacin—Nausea—Irinotecan—colon cancer	0.00131	0.00133	CcSEcCtD
Gemifloxacin—Back pain—Methotrexate—colon cancer	0.00131	0.00132	CcSEcCtD
Gemifloxacin—Dyspepsia—Capecitabine—colon cancer	0.0013	0.00132	CcSEcCtD
Gemifloxacin—Decreased appetite—Capecitabine—colon cancer	0.00129	0.0013	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Capecitabine—colon cancer	0.00128	0.00129	CcSEcCtD
Gemifloxacin—Fatigue—Capecitabine—colon cancer	0.00128	0.00129	CcSEcCtD
Gemifloxacin—Constipation—Capecitabine—colon cancer	0.00127	0.00128	CcSEcCtD
Gemifloxacin—Pain—Capecitabine—colon cancer	0.00127	0.00128	CcSEcCtD
Gemifloxacin—Nausea—Fluorouracil—colon cancer	0.00126	0.00127	CcSEcCtD
Gemifloxacin—Anaemia—Methotrexate—colon cancer	0.00125	0.00126	CcSEcCtD
Gemifloxacin—Vertigo—Methotrexate—colon cancer	0.00121	0.00122	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Capecitabine—colon cancer	0.00121	0.00122	CcSEcCtD
Gemifloxacin—Leukopenia—Methotrexate—colon cancer	0.00121	0.00122	CcSEcCtD
Gemifloxacin—Urticaria—Capecitabine—colon cancer	0.00118	0.00119	CcSEcCtD
Gemifloxacin—Abdominal pain—Capecitabine—colon cancer	0.00117	0.00118	CcSEcCtD
Gemifloxacin—Body temperature increased—Capecitabine—colon cancer	0.00117	0.00118	CcSEcCtD
Gemifloxacin—Arthralgia—Methotrexate—colon cancer	0.00115	0.00116	CcSEcCtD
Gemifloxacin—Myalgia—Methotrexate—colon cancer	0.00115	0.00116	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00114	0.00115	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Methotrexate—colon cancer	0.0011	0.00111	CcSEcCtD
Gemifloxacin—Nervous system disorder—Methotrexate—colon cancer	0.00108	0.00109	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Methotrexate—colon cancer	0.00108	0.00109	CcSEcCtD
Gemifloxacin—Skin disorder—Methotrexate—colon cancer	0.00107	0.00108	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Methotrexate—colon cancer	0.00107	0.00108	CcSEcCtD
Gemifloxacin—Asthenia—Capecitabine—colon cancer	0.00106	0.00107	CcSEcCtD
Gemifloxacin—Anorexia—Methotrexate—colon cancer	0.00105	0.00106	CcSEcCtD
Gemifloxacin—Pruritus—Capecitabine—colon cancer	0.00105	0.00106	CcSEcCtD
Gemifloxacin—Diarrhoea—Capecitabine—colon cancer	0.00101	0.00102	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.001	0.00101	CcSEcCtD
Gemifloxacin—Insomnia—Methotrexate—colon cancer	0.000998	0.00101	CcSEcCtD
Gemifloxacin—Dyspnoea—Methotrexate—colon cancer	0.000983	0.000992	CcSEcCtD
Gemifloxacin—Somnolence—Methotrexate—colon cancer	0.00098	0.000989	CcSEcCtD
Gemifloxacin—Dizziness—Capecitabine—colon cancer	0.00098	0.000988	CcSEcCtD
Gemifloxacin—Dyspepsia—Methotrexate—colon cancer	0.000971	0.000979	CcSEcCtD
Gemifloxacin—Decreased appetite—Methotrexate—colon cancer	0.000959	0.000967	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Methotrexate—colon cancer	0.000952	0.000961	CcSEcCtD
Gemifloxacin—Fatigue—Methotrexate—colon cancer	0.000951	0.000959	CcSEcCtD
Gemifloxacin—Pain—Methotrexate—colon cancer	0.000943	0.000951	CcSEcCtD
Gemifloxacin—Vomiting—Capecitabine—colon cancer	0.000942	0.00095	CcSEcCtD
Gemifloxacin—Rash—Capecitabine—colon cancer	0.000934	0.000942	CcSEcCtD
Gemifloxacin—Dermatitis—Capecitabine—colon cancer	0.000933	0.000942	CcSEcCtD
Gemifloxacin—Headache—Capecitabine—colon cancer	0.000928	0.000936	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Methotrexate—colon cancer	0.000902	0.00091	CcSEcCtD
Gemifloxacin—Nausea—Capecitabine—colon cancer	0.00088	0.000888	CcSEcCtD
Gemifloxacin—Urticaria—Methotrexate—colon cancer	0.000876	0.000884	CcSEcCtD
Gemifloxacin—Abdominal pain—Methotrexate—colon cancer	0.000872	0.00088	CcSEcCtD
Gemifloxacin—Body temperature increased—Methotrexate—colon cancer	0.000872	0.00088	CcSEcCtD
Gemifloxacin—Asthenia—Methotrexate—colon cancer	0.000791	0.000798	CcSEcCtD
Gemifloxacin—Pruritus—Methotrexate—colon cancer	0.00078	0.000787	CcSEcCtD
Gemifloxacin—Diarrhoea—Methotrexate—colon cancer	0.000755	0.000761	CcSEcCtD
Gemifloxacin—Dizziness—Methotrexate—colon cancer	0.000729	0.000736	CcSEcCtD
Gemifloxacin—Vomiting—Methotrexate—colon cancer	0.000701	0.000707	CcSEcCtD
Gemifloxacin—Rash—Methotrexate—colon cancer	0.000695	0.000702	CcSEcCtD
Gemifloxacin—Dermatitis—Methotrexate—colon cancer	0.000695	0.000701	CcSEcCtD
Gemifloxacin—Headache—Methotrexate—colon cancer	0.000691	0.000697	CcSEcCtD
Gemifloxacin—Nausea—Methotrexate—colon cancer	0.000655	0.000661	CcSEcCtD
